Ph.D., MBA (Santa Clara, 2005)
Director of Strategic Research Development, Stanford University School of Medicine
Dr. Helms has 10 years of broad and increasingly responsible experience in the biotechnology industry, encompassing diagnostics, pharmaceutical, and scientific tool companies. While at LJL BioSystems, acquired by Molecular Devices, he developed fluorescence-based detection technologies for high-throughput screening of pharmaceuticals. He then applied his technological skills at Exelixis, a South San Francisco pharmaceutical company, where he led the new lead discovery team, and then at Quidel Corp. in Santa Clara, where he developed high-sensitivity diagnostic devices for infectious diseases. While at ARK Diagnostics, he gained experience in business development, regulatory affairs, and intellectual property, authoring several patent applications. Most recently, he was General Manager of the Sunnyvale Research Center at Complete Genomics, where he directed efforts to sequence single molecules of human DNA and managed a large (5-year, $10 million) federal grant.
In his current role at Stanford, he assists faculty with identifying and applying for grants, both federal and non-federal, as well as consulting for small companies wishing to apply for small business grants. He is a frequent reviewer for an NIH study section for small business (SBIR) grants.
Dr. Helms holds a PhD in biochemistry from the University of Hawaii and an MBA from Santa Clara University with dual concentrations in managing innovation and technology and international business. He is an author on 19 papers and 7 patent applications, and has given lectures and poster presentations around the world.